Foreign patients arriving in Korea for cosmetic and specialist treatment increasingly reach the clinic through an agency rather than on their own, the Korea JoongAng Daily reported. The country holds about 1,200 plastic surgery clinics, and the paper described medical tourism agencies as the intermediaries that plan the trip, book the clinic and manage the recovery for patients who do not speak Korean and cannot easily weigh one surgeon against another. The agency, in that account, sits between the patient and the operating theatre.
An industry built on choice
The scale of choice is what makes the agencies load-bearing. As of 2024 Korea had 1,195 plastic surgery clinics, up 20.6 per cent from 991 in 2019, according to figures from Rep. Kim Mi-ae drawn from the Health Insurance Review and Assessment Service, and dermatology clinics grew 11.8 per cent over the same period. The paper reported that domestic patients often approach clinics directly, comparing surgeons and prices, while foreign patients tend to start with an agency found online. Agencies run under several structures, from the government-backed Medical Korea Info Center to numerous private firms. Korea has built the demand faster than it has built the rules around the people who guide it, and foreign patient numbers have passed two million.
From the airport to the follow-up
What the agencies sell is coordination from first message to final check-up. Eugenia Hwang, a general manager at the agency Docfinderkorea, told the paper that managers greet patients at the airport and accompany them to every clinic visit, and that the work runs well past the clinical. Many patients book bundled packages that compress procedures into a few days, from Botox and skin boosters to eyelid surgery and rhinoplasty. ‘For our company, even shopping or light sightseeing are standard for surgery patients,’ Hwang said, adding that managers arrange meals during recovery, including halal, vegetarian and vegan options. Support continues into the post-surgical period, when managers deliver care kits and medications and escort patients to follow-up appointments. That level of support, Hwang said, can be ‘especially reassuring for patients who do not speak Korean’ and are recovering in an unfamiliar place.
The translator in the room
The reporting is candid about how much of the decision the intermediary carries. Many agency managers began as translators, Eugenia Hwang among them, and the paper drew out how far the role reaches beyond language. ‘A lot of doctors use medical terms that are very hard to understand if you are not in the medical field,’ said Maiya Kogay, who has spent seven years in the K-beauty industry and now works as a marketing manager at a clinic. Eugenia Hwang put a number on it, telling the paper that around 50 per cent of a patient’s final decision is influenced by the manager or translator assisting them, and that the same person often talks a patient down from expectations formed online that are unrealistic or unsafe. Maiya Kogay said she has interpreted for whole families at once, ‘even four of them’, translating separately for each. Maiya Kogay described the job as ‘like a concierge’, a companion available around the clock during the stay.
Payment, training and the gap
This layer carries little formal control. No certification is required to work as a translator in Korean agencies and clinics, Eugenia Hwang said, though fluency in at least two languages is treated as essential, and most companies provide two to three weeks of training before a manager starts. Both women are overseas Koreans who began by interpreting for English-speaking patients, and Eugenia Hwang worked mostly as a translator in her first year. Entry-level pay begins at about 30 million won, or 20,720 dollars, a year, with performance-based raises. The paper reported the training as short and the judgement as learned on the job, which matters because the same untrained intermediary can shape half of a clinical decision.
There is a settled way to read this. The intermediary exists because the patient cannot see the market clearly, and 1,195 plastic surgery clinics is more choice than a foreign patient can weigh, with language and distance widening the gap the agency fills. That gap is the agency’s value and its risk at once. A manager who steers a patient toward a conservative, safer plan is doing patient advocacy; the same influence, pointed the other way by commercial incentive, is a conflict the current setup does not formally check. Agencies are expanding their foreign-patient services as fast as the clinics fill.
The tests are countable. Whether Korea moves from voluntary practice to any certification for medical translators, whether agencies disclose the commercial ties behind a recommendation, and whether the next clinic count climbs again from 1,195 will show whether the guidance layer is being governed or simply left to grow with the trade.
